Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001214659-26-000190
Filing Date
2026-01-06
Accepted
2026-01-06 16:07:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT NO. 12 p16265424b3.htm 424B3 16806
  Complete submission text file 0001214659-26-000190.txt   18035
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279994 | Film No.: 26511479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)